NDC-12: Time Waits for No One

As discussions and building awareness about NDC-12 continue across the US Healthcare industry, one recurring issue is that the timeline is frequently misunderstood—resulting in delays in defining the potential impact and allocating the resources and budget needed to begin the transition.

When many first hear of the 2033 Effective Date and the end of the Transition Period of 2036, the natural inclination is “oh, we don’t have to worry about NDC-12 for years”.  After all, surely there is time before meaningful planning and any real work needs to begin, and we can push off thinking about NDC12 for a couple of years, right? 

On the contrary, many industry leaders that have been immersed in workgroups, pilots, and deep industry conversations are beginning to view the timeline differently.

The questions really are: What do we have to do? By when? By whom? And what is the extent of the scope?  How much time is actually available once an organization accounts for impact assessments, cross-functional team formation, funding cycles, competing priorities, planned system changes, partner coordination, internal testing, label and artwork changes and interoperable industry testing. 

The answer may be less time than many expect as there’s a movement in the industry to plan for interoperable industry testing to start as soon as 2030, which means that the work internally for a manufacturer needs to be front-loaded in the first part of this seven-year journey. 

This is also not necessarily a one-size-fits-all problem.  The higher the number of SKUs the more complex the problem.  A virtual biotech manufacturer with one or two products likely has much less of a heavy lift than a large multi-national generics company with hundreds or thousands of products.

Looking Beyond the Effective Date

Large-scale industry transformations rarely begin with implementation. They begin with awareness, assessment, strategy, and understanding of every hidden corner of the eco-system where the NDC-12 shows up, including, of course, artwork and labeling.

Before anything can be modified, organizations must understand where the 10-and 11-digit NDC product identifiers are used. Before budgets can be approved, impacts must be quantified, and priorities and dependencies identified. Before testing or labeling changes can begin, stakeholders across regulatory, manufacturing, supply chain, commercial, finance, quality, and IT must align around priorities and ownership.  In other words, a lot of work needs to be planned, scheduled, resourced, and executed.

NDC-12 introduces an additional challenge: no organization can prepare in isolation.

Success ultimately depends on interoperability across manufacturers, distributors, dispensers, technology and business solution providers, and government stakeholders. Systems must exchange information consistently. Products must be identified and labeled accurately. Business processes must continue to function across an interconnected ecosystem.

If the industry expects broad external testing to begin around 2030, organizations will need to work backward from that milestone rather than from the eventual effective date.

Viewed through that lens, the timeline becomes less about when implementation starts, and more about how quickly organizations can establish visibility, ownership, and a measurable plan.

The Transition Period Is Often Misinterpreted

A second area of confusion involves the transition period itself.

It is understandable why some organizations view the transition period as additional time to complete remediation activities. Historically, the phrase “transition period" in some IT circles is often associated with ongoing implementation – e.g. transition or cutover from one system to another.

However, the NDC-12 transition period exists to allow products carrying 10-digit and 12-digit identifiers to coexist within the marketplace while the industry gradually transitions inventory to eventually bleed out all 10-digit inventory, all while launching new NDC-12 only products. It is not intended to be the period during which organizations begin redesigning business processes, modifying applications, or validating integrations.  Those activities must be completed beforehand. By the time the transition period begins, artwork, labels, systems, processes, trading partner connections, reporting capabilities, and operational procedures should already be functioning in a manner that supports NDC-12.

The challenge during the transition period is not implementation, but rather coexistence of multiple formats in production processes.

Organizations will need to manage products, transactions, and business processes across multiple identifier formats while maintaining operational continuity throughout the supply chain.  This is why some people say the NDC-12 transition is harder than Y2K, during which we had a hard date for cutover to a new identifier, rather than a transition period with multiple formats.

The Ownership Question

Perhaps one of the most common questions emerging from current industry discussions is a simple one:

Who owns NDC-12 in my organization? The answer varies significantly from organization to organization, but in many cases, has not yet been established. Some companies have already organized dedicated, cross-functional teams focused on understanding impacts and preparing long-term strategies. Others are still in the awareness stage, where responsibility resides with a single individual attempting to build visibility across the enterprise.

What is becoming increasingly clear, however, is that NDC-12 does not fit neatly within a single department as it is not solely a regulatory initiative, nor solely an IT or packaging initiative. There’s likely no single person in any company that knows how the NDC is used across all processes, from initial product identity to financial settlement.

The identifier touches processes involved in product identity, artwork and labeling, serialization and packaging, manufacturing, distribution, contracting, pricing, ordering, reimbursement, finance, sales, reporting, compliance, and downstream dispensing activities. As a result, organizations that view NDC-12 through a single-functional lens may overlook significant downstream impacts and dependencies. And since so many of these processes are outsourced to 3^rd parties like Contract Packagers and 3PLs, the Partner eco-system also requires tight coordination and communication.

Many of the companies that we’ll call “Early NDC-12 Adopters” have recognized NDC-12 as an enterprise-wide business transformation rather than a discrete compliance project.

What Organizations Are Doing Now

While implementation timelines continue to evolve, leading organizations are already taking practical steps to improve visibility and reduce future risk.

They are beginning impact assessments and labeling and system inventories. They are identifying hidden dependencies and downstream business impacts. They are bringing together stakeholders from IT, Operations, Supply Chain, Regulatory, Compliance, Commercial, and Finance to establish shared ownership. They are incorporating NDC-12 into long-range planning and budgeting discussions. And increasingly, they are evaluating what must be in place before industry-wide testing begins.

Looking Ahead

If there is one lesson emerging from industry conversations today, it is that the NDC-12 timeline may not be as straightforward as it first appears.

The seven-year preparation period should not be viewed as seven years available before action is required. Rather, it should be viewed as the time available to understand impacts, align stakeholders, secure funding, modify systems, plan artwork and labeling strategies, coordinate with trading partners, and ultimately demonstrate interoperability across the healthcare ecosystem.

Likewise, the transition period should not be viewed as time to complete transformation efforts. It is the period during which organizations operate across both 10-digit and 12-digit environments using systems and processes that are already prepared and tested.

In our next article, we will explore the question many organizations are now asking:

Where do we start?

For many companies, the first challenge is not remediation—it is visibility.

Which systems use NDC today? Which business processes depend on it? Where are the hidden downstream impacts? Who should be involved? And how can organizations begin building realistic budgets, timelines, and governance structures for a change that reaches far beyond labeling and packaging?

We will examine what an NDC-12 assessment looks like, how organizations are identifying risks and dependencies, and why many companies are beginning these efforts now in preparation for the industry's expected testing window.